HRDIL yields 1000000.00% · PFE yields 6.13%● Live data
📍 HRDIL pulled ahead of the other in Year 1
Combined, HRDIL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HRDIL + PFE for your $10,000?
Here Media Inc. offers original programming content tailored for the lesbian, gay, bisexual, and transgender (LGBT) community on a subscription basis. The company publishes magazines and books, as well as operates companion Websites targeting the LGBT community. Its products include the magazines Out, The Advocate, and HIVPlus, as well as books published by Alyson Books, which are distributed through traditional newsstands, other retail outlets, and by subscriptions of print and digital editions of the magazines. It also operates PlanetOut, an online media company serving the LGBT community through its website Gay.com, a social networking Website; and a companion Website, heretv.com that features original shows, podcasts, news, and other entertainment, as well as a library of LGBT-themed streaming video. In addition, the company provides subscription video-on-demand and/or regularly scheduled television channel services through cable, satellite, and fiber-optic television providers serving domestic television households in the United States; and syndicates free-to-the-user content to Websites, including msn.com and aol.com. It serves customers through cable television, direct-to-home satellite television, fiber-optic television, and the Internet under the brand name "here!". The company is was founded in 2009 and is headquartered in Los Angeles, California.
Full HRDIL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.